PharmaceuticalsElkton, VirginiaAnnouncement date · Oct 20, 2025

Elkton Center of Excellence for Pharmaceutical Manufacturing

See all projects by Merck →

Merck's $3 billion Center of Excellence for Pharmaceutical Manufacturing is a 400,000 sq ft facility at its long-established Elkton, Virginia site, covering active pharmaceutical ingredient and drug-product investment for small-molecule manufacturing and testing. Construction began with the October 20, 2025 groundbreaking. Merck said the facility could potentially create more than 500 full-time roles; AFT records that conservative 500-job floor and notes the figure remains a company projection. No operating date has been disclosed, so none is recorded. Excluded from these figures: the 8,000 construction jobs, Merck's more-than-$70-billion national investment program, its separately described $3 billion unallocated biologics and small-molecule commitment, and its $3.5 billion Rahway, New Jersey headquarters and research investment. The separate 2019 Elkton HPV vaccine expansion is tracked as its own completed project.

Investment
$3.00B
Permanent jobs announced
500
Status
Under Construction
Opening timeline
Not yet announced
Why this project qualifies

With $3 billion in facility-specific investment and 500 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). This project also meets AFT's primary-source verification and physical U.S. manufacturing-footprint requirements.

View full methodology →
Why it matters

The pharmaceuticals context.

Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.

Project record

At a glance

Company
Merck
Industry
Pharmaceuticals
Location
Elkton, Virginia
Investment
$3.00B
Permanent jobs announced
500
Status
Under Construction
Announced
Oct 20, 2025
Opening timeline
Not yet announced
Added to tracker
Sep 1, 2026
Sources

Official references

Related

Other projects to know

In Virginia
Across Pharmaceuticals
Back to the tracker/projects/merck-elkton-center-of-excellence